Medical Care

Immunovaccine (IMV:CA) Announces Financial Results for the Second Quarter

Spotlight Companies | |

Immunovaccine Inc. (IMV:CA) has released its financial and operational results for the second quarter.

Immunovaccine (IMV: CA) Announces Closing of $10 Million Bought Deal Offering

Spotlight Companies | |

ImmunoVaccine Inc. (IMV: CA) has closed the previously announced bought deal public offering of common shares of the corporation, raising gross proceeds of approximately $10-million.

Sharing Services, Inc. (SHRV) Invests into Medical Smart Care, LLC for Additional Incentive Programs

Spotlight Companies | |

​Sharing Services, Inc. (OTC Markets:SHRV) announced today that it is investing in Medical Smart Care, LLC (“MSC”) and its unique health benefits card program

​PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer

Spotlight Companies | |

PreveCeutical Medical Inc. is pleased to announce the appointment of Dr. Harendra (“Harry”) Parekh, Ph.D., BSc., Hons I, as Chief Research Officer (“CRO”).

​PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Extraction, Formulation and Ex Vivo Evaluation of Cannabinoids (“CBD”s) for Delivery via Sol-Gels

Spotlight Companies | |

PreveCeutical Medical Inc. (“PMI”) is pleased to announce that it has signed a research and development agreement effective April 22, 2017 (the "Agreement") with UniQuest Pty Limited.

Three Companies Spearheading a Shift in the Hepatitis B Healthcare Space

Samuel Rae | |

A look at the frontrunners in one of the fastest growing spaces in healthcare.

Beleave (CSE: BE) and Ryerson University Collaborator Begin Patent Work by Expanding on Recent Genetic Results

Spotlight Companies | |

​Beleave Inc. (CSE: BE) is pleased to announce that it will begin a collaborative research project with Dr. Lesley Campbell, associate professor in the Department of Chemistry and Biology at Ryerson University

Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR

Spotlight Companies | |

​Invictus MD Strategies Corp. (CSE:IMH OTC:IVITF FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”)

Reliq Health (RHT: CA), Invictus MD to Develop App for Cannabis Users

Spotlight Companies | |

​Reliq Health Technologies Inc. (RHT: CA) has entered into a memorandum of understanding (MOU) with Invictus MD Strategies Corp. to develop a mobile application for cannabis patients and consumers and their clinical care teams.

Immunovaccine’s (IMV; IMMVF) Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial

Spotlight Companies | |

​Immunovaccine Inc. (TSX: IMV; OTCQX: IMMVF), a clinical stage immuno-oncology company, today announced that the UHN’s Princess Margaret Cancer Centre (PM) will conduct a Phase 2 clinical trial